Related Experiment Video
Updated: Aug 11, 2026

09:42
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
Published on: April 19, 2017
Gene delivery into human skin in vitro using biphasic lipid vesicles
Marianna Foldvari1, Praveen Kumar, Martin King
1College of Pharmacy and Nutrition, University of Saskatchewan, Saskatoon, SK S7N 5C9, Canada. foldvari@duke.usask.ca
Current Drug Delivery
|February 14, 2006
Summary
Novel lipid-based biphasic vesicles effectively deliver plasmid DNA topically to human skin. This breakthrough advances non-invasive transdermal delivery of large molecules for vaccines and therapeutics.
Area of Science:
- Biotechnology
- Dermatology
- Pharmaceutics
Background:
- Topical gene delivery offers non-invasive administration of vaccines and therapeutics.
- Developing effective delivery systems for plasmid DNA into viable skin layers is crucial.
Purpose of the Study:
- To quantitatively assess DNA delivery into excised human skin using a novel lipid-based biphasic system.
- To evaluate the efficacy of different biphasic vesicle formulations for transdermal macromolecule delivery.
Main Methods:
- In vitro evaluation of lipid-based biphasic vesicle formulations in flow-through diffusion cells using excised human breast skin.
- Quantitative PCR was used to measure plasmid DNA absorption after topical application and washing.
- Skin samples underwent tape-stripping and DNase treatment to isolate dermal absorption.
Main Results:
- Three formulations demonstrated significant dermal absorption compared to controls.
- Formulation 26-3-2-DNA achieved approximately 1x10^9 plasmid copies/cm^2 skin absorption.
- Other formulations showed absorption rates of 5x10^6 to 5x10^8 copies/cm^2 skin.
Conclusions:
- Biphasic vesicles successfully delivered significant quantities of plasmid DNA into the viable layers of human skin in vitro.
- This represents a major advance in transdermal delivery of large, charged molecules like plasmid DNA.
- The system shows potential for painless, non-invasive topical gene therapy and vaccination.

